InMed Pharmaceuticals (INM) Enterprise Value: 2022-2025
Historic Enterprise Value for InMed Pharmaceuticals (INM) over the last 4 years, with Jun 2025 value amounting to -$7.2 million.
- InMed Pharmaceuticals' Enterprise Value fell 71.28% to -$4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.6 million, marking a year-over-year increase of 10.19%. This contributed to the annual value of -$7.2 million for FY2025, which is 63.71% down from last year.
- As of FY2025, InMed Pharmaceuticals' Enterprise Value stood at -$7.2 million, which was down 63.71% from -$4.4 million recorded in FY2024.
- Over the past 5 years, InMed Pharmaceuticals' Enterprise Value peaked at $665,692 during FY2022, and registered a low of -$7.2 million during FY2025.
- Its 3-year average for Enterprise Value is -$5.8 million, with a median of -$5.9 million in 2023.
- Per our database at Business Quant, InMed Pharmaceuticals' Enterprise Value plummeted by 982.29% in 2023 and then rose by 25.16% in 2024.
- Over the past 4 years, InMed Pharmaceuticals' Enterprise Value (MRY) stood at $665,692 in 2022, then tumbled by 982.29% to -$5.9 million in 2023, then grew by 25.16% to -$4.4 million in 2024, then crashed by 63.71% to -$7.2 million in 2025.
- Its Enterprise Value was -$7.2 million in FY2025, compared to -$4.4 million in FY2024 and -$5.9 million in FY2023.